-
-
-
-
-
-
-
CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights
-
-
-
-
-
-
-
Cytosorbents (CTSO) Tops Q4 EPS by 2c, Misses on Revenue
-
-
-
-
-
-
-
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue
-
-
-
-
-
-
-
CytoSorbents to Report Second Quarter 2024 Operating and Financial Results
-
-
-
-
-
-
-
CytoSorbents to Report Fiscal 2023 Operating and Financial Results
-
-
-
-
-
-
-
Cytosorbents (CTSO) Misses Q1 EPS by 4c
-
-
-
-
-
-
-
CytoSorbents’ Pivotal STAR-T Trial Reaches Second Key Milestone With 80 Patients Enrolled
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

